Methods and compositions for reducing clostridium difficile infection
AssigneeMemorial Sloan Kettering Cancer Center
InventorsEric Pamer, Charlie Buffie, Peter McKenney
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for reducing the risk and severity of C. difficile infection. It is based, at least in part, on the discovery that a restricted fraction of the gut microbiota, including the bacterium Clostridium scindens, contributes substantially to resistance against C. difficile infection. Without being bound by any particular theory, it is believed that this is achieved through the biosynthesis of secondary bile acids.
Claims21
1-42. (canceled)
A composition comprising a first isolated bacteria or spores thereof being Clostridium scindens expressing an enzyme that converts a bile acid to a secondary bile acid and a second isolated bacteria or spores thereof being selected from the group consisting of Clostridium hiranonis, Clostridium hylemonae, Clostridium sordellii, and a combination thereof.
Dependencies are inferred from the claim text.